Astellas Venture Management, LLC, a wholly-owned venture capital subsidiary of Japan based Astellas Pharma Inc., and US based Mission Bay Capital BioLabs, a life-science incubator, have announced their collaboration on the "Golden Ticket Competition".

A Golden Ticket offers entrepreneurial scientists or emerging biotechnology start-ups one-year usage of MBC BioLabs' state-of-the-art lab facility and access to Astellas' research and development (R&D) capabilities and business leaders.

Astellas' sponsorship of the Golden Ticket Competition follows AVM becoming a limited Partner of the venture capital firm Mission Bay Capital in May 2019 and obtaining Gold Sponsorship of MBC BioLabs.

With a shared commitment to discovering and advancing innovative science for the potential future benefit of patients worldwide, AVM and MBC BioLabs are proud to support scientists and early-stage companies to accelerate their novel therapeutic programs, modalities or platforms.